REP. BARTON SCHEDULES HEARING ON FDA RELEASE OF CONFIDENTIAL DATA TO SUMMIT; CONGRESSIONAL SCRUTINY KEEPS PRESSURE ON AGENCY TO FINISH PROBE
This article was originally published in The Gray Sheet
Executive SummaryFDA's release of confidential documents to excimer laser manufacturer Summit Technology will be scrutinized at a hearing scheduled for July 31 by Rep. Joe Barton's (R-Tex.) House Commerce/Oversight Subcommittee. Witnesses have not been finalized but likely will include agency and industry representatives.
You may also be interested in...
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.
Slovenia’s Krka has responded to media reports of “irregularities” at its Romanian subsidiary – including allegations of bribing local doctors to prescribe its products – by pledging to form a special investigation team to immediately examine the matter.